Yihe Jiaye (301367): Cultivating domestically while looking to the Global market, the domestic leader in home Ventilators is writing a new chapter.

The domestic leader in complete product lines of home Ventilators is expected to experience a dual resonance of performance recovery and profit enhancement. The company has been deeply involved in the respiratory sleep field for over twenty years, with a well-structured product line covering three major areas: home use, medical use, and consumables. The company holds

Guosheng SecuritiesJan 4 00:00

Yihe Jiaye (301367.SZ): has repurchased a total of 0.78% of its shares.

On January 2, Gelonghui reported that Yihe Jiaye (301367.SZ) announced that as of December 31, 2024, the company had repurchased shares through a dedicated Share Buyback securities Account via centralized bidding trading, with a total of 694,780 shares repurchased, accounting for 0.78% of the company's current total share capital. The highest Fill Price for the buyback was 68.00 yuan/share, the lowest Fill Price was 57.62 yuan/share, and the total amount spent was 42.2523 million yuan (excluding transaction fees).

Gelonghui FinanceJan 2 18:22

Yihe Jiaye (301367.SZ): Ventilators, oxygen generators, and consumable products are currently sold at Pang Donglai Pharmaceutical Supermarket.

Gelonghui, January 2nd丨Yihe Jiaye (301367.SZ) stated on the investor interaction platform that the company's Ventilator, oxygen generator, and consumable products are currently sold at Pang Donglai Pharmacy Supermarket.

Gelonghui FinanceJan 2 15:49

Guolian: It is the right time for domestic medical instruments to go global. Focus on leading companies with first-mover advantages in going abroad.

Domestic medical instruments have advantages in production, manufacturing, and upgrades, laying a foundation for products to go global, and the Global medical instruments market has vast potential.

Zhitong FinanceJan 2 15:02

Yihua Jiaye (301367): Technology + brand + sales advantages lead the coordinated development of domestic and foreign markets.

Investment highlights once again cover Yihe Jiaye (301367) with an outperform industry rating, Target Price of 86.00 yuan, corresponding to a PE of 28.5 times for 2025. Reasons are as follows: Global and China respiratory health medical instruments industry prosperity.

China International Capital CorporationDec 21, 2024 11:27

Yihe Jiaye (301367): Policy support for purchasing domestic products, the domestic market is expected to benefit.

On December 5, the Ministry of Finance released a notice regarding the "Notice on Standards and Implementation Policies for Domestic Products in the Government Procurement Field (Draft for Comment)" to publicly solicit opinions from society. Support for government procurement of domestic products is provided: 1)

TianfengDec 16, 2024 07:52